Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A phase I, randomized, placebo-controlled, double-blind, ascending-dose and single-center study to evaluate immunogenicity and safety of a live attenuated tetravalent dengue vaccine (KD-382) in Flavivirus antibody-naïve healthy adults1 passage
• A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe1 passage
• Adult vaccination uptake strategies in low- and middle-income countries: A systematic review1 passage
• Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report1 passage
• Cost-effectiveness of adult vaccinations: A systematic review1 passage
• Evaluation of the impact of different notification methods for unvaccinated individuals in a ACWY meningococcal vaccination campaign1 passage
• Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling1 passage
• Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study1 passage
• Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis1 passage
• Impact of patient and provider nudges on addressing herpes zoster vaccine series completion1 passage
• Incidence and bacterial etiology of acute otitis media in children in the pneumococcal conjugate vaccine era: A systematic literature review and meta-analysis1 passage
• Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis1 passage
• Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya1 passage